Long-term Outcomes of Ablative Stereotactic Body Radiation Therapy for Inoperable, Non-metastatic Pancreatic Cancer
Cao BY, Zhang LT, Wu CC, Wang J | Radiother Oncol. | 2025
Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
Zhang Z, Tian B, Xu H, Huang H, Liang X, Bo C, Bian Y, Wei M, Zhao Z | Cancer Manag Res | 2025
Five-Year Outcomes of Robotic Stereotactic Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer
Tal Sherman et al. | ASTRO | 2025
Stereotactic Radiotherapy Boost in Locally Advanced Cervical Carcinoma Patients (STARBACS): Up-to-Date Results of a Phase II, Single Arm, Monoinstitutional Study
Silvana Parisi et al. | ASTRO | 2025
Stereotactic Body Radiotherapy for the Treatment of Oligometastases Located in the Peritoneum or in the Abdominal Wall: Preliminary Results from a Mono-Institutional Analysis
Francesco Cuccia et al. | ASTRO | 2025
Stereotactic Body Radiotherapy (SBRT) Boost Following Urgent 3D Conformal Radiotherapy in the Treatment of Metastatic Epidural Spinal Cord Compression (MESCC): A Phase I Feasibility Trial
Elysia Donovan et al. | ASTRO | 2025
The Effect of Radiation Techniques on Carbon Footprint Reduction
Yu-Hsuan Chuang et al. | ASTRO | 2025
The Changing Dogma in Oligometastatic Renal Cell Carcinoma – SBRT
Papaiah Susheela Sridhar et al. | ASTRO | 2025
Clinical Application of Simultaneous Integrated Boost in Stereotactic Body Radiotherapy for Large-Volume Tumors: A Single-Center Retrospective Study
Min Zhao et al. | ASTRO | 2025
Ablative Radiotherapy for Inoperable Non-Metastatic Pancreatic Cancer: Long-Term Results in a Single Center
Jing Wang et al. | ASTRO | 2025
Frameless Robotic Radiosurgery System Stereotactic Body Radiation Therapy (SBRT) Dose Escalation Prostate Cancer Trial (CK-DESPOT) for Unfavorable Intermediate and High-Risk
Mark Nguyen et al. | ASTRO | 2025
Urethra Sparing in Robotic SBRT for Localized Prostate Cancer with Simultaneous Focal Boost to MR-Defined High PI-RADS Score Intra-Prostatic Lesions: A Dosimetric Analysis
Hong Xiang et al. | ASTRO | 2025
Reirradiation with SBRT in Radiorecurrent Prostate Cancer: Impact on Disease Control and Quality of Life Outcomes
Papaiah Sridhar et al. | ASTRO | 2025
PSMA Based Dose Escalation to Dominant Intraprostatic Lesion (DIL) in Localized Carcinoma Prostate Treated with Stereotactic Body Radiotherapy
Papaiah Susheela Sridhar et al. | ASTRO | 2025
Optimizing PTV Generation and Comparison of OAR Dosimetry with Different Rectal Spacers in Patients Treated with HDR-Like Prostate SBRT
Emily Hollis et al. | ASTRO | 2025
Stereotactic Body Radiation Therapy to Only Prostate and Proximal Seminal Vesicles is a Viable Option for a Favorable Subset of High-Risk Prostate Cancer Patients
Nima Aghdam et al. | ASTRO | 2025
To Space or Not to Space: The EPIC question for Prostate Stereotactic Radiation (SBRT) with or without Hydrogel Rectal Spacer (RS)
Madeline Flanagan et al. | ASTRO | 2025
MRI PI-RADS Lesion Location in Transitional vs. Peripheral Zone and Impact on Acute GU Toxicity Following Prostate SBRT Microboost
Jonathan Lischalk et al. | ASTRO | 2025
Stereotactic Reirradiation with CyberKnife for Locally Recurrent Prostate Cancer, Long-term Toxicity and Clinical Outcomes from a Monocentric Cohort
Francolini G, Carnevale MG, Di Cataldo V, Loi M, Detti B, Orsatti C, Caprara L, Bertini N, Lorenzetti V, Olmetto E, Becherini C, Visani L, Salvestrini V, Simontacchi G, Greto D, Bonomo P, Doro R, Masi L, Desideri I, Meattini I, Serni S, Livi L | Radiol Med | 2023
Intensity Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: Five-year Outcomes
Carrasquilla M, Sholklapper T, Pepin AN, Hodgins N, Lei S, Rashid A, Danner M, Zwart A, Bolanos G, Ayoob M, Yung T, Aghdam N, Collins B, Suy S, Kumar D, Hankins R, Kowalczyk K, Dawson N, Collins S | Front Oncol | 2023
